Advertisement
News
Subscribe to MDT Magazine News

NuVasive posts higher 3Q profit but cuts outlook

October 28, 2010 3:45 pm | Comments

NuVasive Inc. said Thursday its profit climbed in the third quarter as the medical device maker's revenue grew 27 percent.But its shares tumbled sharply because the company downwardly revised its earnings and revenue estimates for the year.NuVasive reported net income of $8.5 million, or 21...

Colorectal Cancer Teleconference

October 28, 2010 1:32 pm | by AACR | Comments

Colorectal cancer is the third leading cause of cancer in men and women. Listen to the press conference hosted by Rustgi on Thursday, Oct. 28.

TOPICS:

Analyzed relation between sleep disorders and risk perception by drivers with disorder

October 28, 2010 12:34 pm | by EurekAlert | Comments

(University of Granada) Researchers at the University of Granada are analyzing how sleep disorders affect risk perception in driving. For the purpose of their study, the Faculty of Psychology employed three last-generation simulators developed by the company Honda Motor Co.

TOPICS:
Advertisement

Scientists investigate evolution of new polio virus

October 28, 2010 12:34 pm | by EurekAlert | Comments

(University of Liverpool) Scientists at the University of Liverpool have completed the first major review of diagnostic methods and treatments for a rapidly evolving virus that causes hand, foot and mouth disease in children.

TOPICS:

Varian Medical Systems to Exhibit TrueBeam™ System for Image-Guided Cancer Treatments and New Software Capabilities at ASTRO Meeting in San Diego

October 28, 2010 12:31 pm | by Bio-Medicine.Org | Comments

SAN DIEGO, Oct. 28 /- ASTRO Booth # 201 -- Varian Medical Systems (NYSE: VAR ) will highlight its new TrueBeam™ system for fast, powerful and efficient cancer treatments at the 52nd annual meeting of the American Society for Radiation Oncology (ASTRO) meeting in San Diego next week....

TOPICS:

Scientists call for tighter regulations on food adverts during children's TV viewing

October 28, 2010 11:36 am | by EurekAlert | Comments

(University of Liverpool) Psychologists at the University of Liverpool have called for tighter advertising regulations after a study revealed unhealthy foods are more likely to be advertised during children's peak viewing times than at any other point in the broadcasting schedule.

TOPICS:

Huge 'biobank' for research into major diseases to be set up by Qatar and Imperial College London

October 28, 2010 11:36 am | by EurekAlert | Comments

(Imperial College London) A "biobank" of samples and clinical measurements from tens of thousands of people is to be established in Qatar to help scientists understand the causes of major diseases and develop new treatments, it is announced today.

TOPICS:

Alliance Seating & Mobility Supports Community Efforts to Help Paralyzed North Carolina Resident

October 28, 2010 11:34 am | by Bio-Medicine.Org | Comments

SALISBURY, N.C., Oct. 28 /- Salisbury resident Tim Elrod was severely injured in a vehicle accident approximately one year ago. After several months and multiple hospital stays, he returned home paralyzed from the waist down, confined to a manual wheelchair that was covered by his...

TOPICS:
Advertisement

Technology, New Therapies Reduce Use of Addictive Prescriptions

October 28, 2010 11:34 am | by Bio-Medicine.Org | Comments

WEST PALM BEACH, Fla., Oct. 28 /- The truth is...not all pain is created equal.  Acute pain is where it all begins.  Lasting for several months, acute pain is typically treated with rest, time and medication.  For many, that is enough.   But if the pain persists, it...

TOPICS:

IRIDEX Announces Third Quarter 2010 Conference Call and Release Date

October 28, 2010 11:33 am | by Bio-Medicine.Org | Comments

MOUNTAIN VIEW, Calif., Oct. 28 /- IRIDEX Corporation (Nasdaq: IRIX ) today announced that it will release its third quarter 2010 financial results after the market closes on Thursday, November 4, 2010.  In conjunction with the release, the Company will host a conference call with the...

TOPICS:

FDA Approves Additional Medical Indication for Sprycel

October 28, 2010 11:33 am | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., Oct. 28 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved a new indication for Sprycel (dasatinib) for the treatment of a rare blood cancer when it is first diagnosed. The cancer, called Philadelphia chromosome positive chronic phase...

TOPICS:

Jekyll-Hyde MicroRNA Binding Variant Linked to Improved Outcome in Early-stage Colorectal Cancer

October 28, 2010 11:33 am | by AACR | Comments

PHILADELPHIA — A variant site linked to poor outcome in advanced colorectal cancer has now been found to predict improved prognosis in early stages of cancer, according to research presented at the American Association for Cancer Research special conference on Colorectal Cancer: Biology...

TOPICS:

New Colorectal Screening Test Measures DNA Methylation

October 28, 2010 11:32 am | by AACR | Comments

PHILADELPHIA — Results from a validation study of a new DNA methylation screening tool for colorectal cancer will be presented at the American Association for Cancer Research special conference on Colorectal Cancer: Biology to Therapy, held here Oct. 27-30, 2010.

TOPICS:

FAK Inhibitor Effectively Blocked Colon Cancer Cell Growth and Viability

October 28, 2010 11:32 am | by AACR | Comments

PHILADELPHIA — Researchers are one step closer to providing a new therapy for colon cancer, after findings revealed that a small molecule focal adhesion kinase (FAK) inhibitor known as Y15 effectively blocked cell viability, promoted detachment and apoptosis, and decreased tumor growth in...

TOPICS:

Dentsply International's 3Q profit falls

October 28, 2010 10:45 am | by The Associated Press | Comments

Dental products maker Dentsply International Inc. said Thursday its third-quarter profit fell nearly 6 percent on higher costs.Dentsply said it earned $63.7 million, or 44 cents per share, down from $67.5 million, or 45 cents per share, a year earlier.Revenue rose 2 percent to $541.8 million...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading